Beruflich Dokumente
Kultur Dokumente
ISSN: 22312781
ABSTRACT
This review deals with discussion of the conventional as well as sophisticated chromatographic
techniques from the standpoint of its working principle and applicability for diverse samples.
Depending upon a wide range of test samplesof different physical and chemical properties to be
separated, the specific chromatographic method is selected which justifies the separation,
identification and analysis with optimum outcomes for that particular sample. The study signifies
the appliance of chromatography at various stages of drug discovery and development. The
aptness of various chromatographic methods for different types of components to be separated
was reviewed.
282
IJRPC 2013, 3(2) Manisha Chavan et al. ISSN: 22312781
283
IJRPC 2013, 3(2) Manisha Chavan et al. ISSN: 22312781
stationary phase is liquid it is referred as gas- GC or LC. These compound (1) are either
liquid partition chromatography. The latter is nonvolatile or thermally unstable so the that
mostly used technique. The stationary phase GC procedures are inapplicable and (2)
is held in a narrow column in an oven. While contain no functional groups that make
gaseous mobile phase travels through column. possible detection by the spectroscopic or
In Gas chromatography, the solutes of a electrochemical techniques used in HPLC 7.
vaporized sample are separated as
consequence of being partitioned between a Chiral chromatography
mobile gaseous phase and a liquid stationary Chiral chromatography involves the separation
phase held in a column. Unlike most other of stereoisomers. In the case of enantiomers,
type of chromatography, the mobile phase these have no chemical or physical differences
does not interact with molecules of analyte but apart from being three-dimensional mirror
only transport the analyte5 through the images. Conventional chromatography or
column.The technique is applicable to complex other separation processes are incapable of
organic, metal-organic biochemical entities separating them. To enable chiral separations
made of volatile species and generally to take place, either the mobile phase or the
thermostable compounds7. stationary phase must themselves be made
chiral, giving differing affinities between the
High performance liquid chromatography analytes. Chiral chromatography HPLC
(HPLC) columns (with a chiral stationary phase) in
Liquid chromatography is similar to gas both normal and reversed phase8 are
chromatography but uses a liquid mobile commerciallyavailable.
phase. The stationary phase is usually an inert Many of the drugs are available in its racemic
solid or a liquid held on the inert solid. Mobile mixture form after synthesis. Only one of the
phase travels through the column forcibly with enantiomer is having therapeutic activity and
the aid of the high pressure pump. Solutes of other enantiomer is either inactive or having
the sample separated on column and eluted adverse reactions. It is very important to
with mobile phase5. separate them, Separation of the enantiomers
The technique is applicable to thermally fragile comprising the racemate, i.e., the resolution of
samples, e.g. amino acids, proteins, nucleic the racemate, is a common problem in
acids, hydrocarbons, antibiotics, steroids, stereochemical research as well as in the
drugs, inorganic and may organic substances7. preparation of biologically active compounds,
in particular, drugs. Chiral chromatograph
Affinity chromatography made feasible to separate these racemic
Affinity chromatography is based on selective mixtures.
non-covalent interaction between an analyte
and affinity ligand. These affinity ligands are High Performance Thin Layer
antibodies, enzyme inhibitors which selectively Chromatography (HPTLC)
and reversibly bind to analyte molecules in the High-performance thin-layer chromatography
sample. These affinity ligands are covalently (HPTLC) is a form of thin-layer
bonded to the solid support. When sample chromatography (TLC) that provides superior
passes through the column, these ligands bind separation power using optimized coating
selectively to some of the analyte molecule material, automated procedures for mobile-
and other molecules may elute out. Once phase feeding, layer preconditioning, précised
these eluted out retained molecule may be sample application, chromatogram
made to elute by changing the elution development scanning, and photo-
parameters.Affinity chromatography often documentation. It promotes for higher
utilized to analyze biomolecules7. separation efficiencies, shorter analysis time,
lower amounts of mobile phase, and efficient
Supercritical fluid chromatography (SFC) data acquisition and processing.
Supercritical fluid chromatography is a HPTLC has strong potentials as a surrogate
separation technique in which the mobile chromatographic model9for estimating
phase is a fluid above and relatively close to partitioning properties in support of
its critical temperature and pressure. SFC is a combinatorial chemistry, environmental fate,
hybrid of a gas chromatography and liquid and health effect studies9. The method can be
chromatography that combines some of the used to validate the simultaneous estimation
best features of each. For certain applications of two or more drug combinations in a dosage
it is superior to GC and LC. SFC permits the form10.
separation and determination of group of One of the available chromatographic
compounds not conveniently handled by either techniques is HPTLC, which is used for the
284
IJRPC 2013, 3(2) Manisha Chavan et al. ISSN: 22312781
285
IJRPC 2013, 3(2) Manisha Chavan et al. ISSN: 22312781
pharmacological effect is restricted in most of and cost of analysis. The novel generic
the cases to one of the enantiomers. Only UPLC/MS/MSmethodology was successfully
about 25% of drugs are administered as pure introduced within early Drug Discovery and
enantiomers. There can be qualitative and resulted in a four-fold increase of throughput
quantitative differences in the activity of the as well as a significant increase in sensitivity
enantiomers. The pharmacologically inactive compared to other in-house generic LC/MS
enantiomers can show unwanted side effects; methods23.
in some cases antagonistic and even toxic Affinity-based chiral separations and the use
effects are observed. The enantiomers can of affinity chromatography for the study of drug
differ in absorption, distribution, protein binding or hormone interactions with binding proteins.
and affinity to the receptor. Furthermore, the Some areas of possible future developments
metabolic pathways can differ. Therefore, the are then considered, such as tandem affinity
separation of racemic mixtures of intermediate methods and the use of synthetic dyes,
or final products is often required. For immobilized metal ions, molecular imprints, as
enantiomers’ separation on analytical scale affinity ligands for clinical analytes17.
agreat variety of methods based on chiral Ion exchange chromatography has been
chromatographic techniques such as HPLC, applied to a variety of organic and biochemical
GC, SFC, TLChave been developed where systems, drugs, their metabolites serum, food
chiral reagent is added in mobile phase or preservative, vitamin mixtures, and
chiral stationary phase is used21. pharmaceutical preparations. Ion exchange is
Capillary column gas chromatography probably the most frequently used
(GC)/mass spectrometry (MS) have been used chromatographic technique for the separation
to achieve more powerful separation and to and purification of proteins, polypeptides,
perform structural analysis of molecules. The nucleic acids, polynucleotides and other
development of high-performance liquid charged biomolecules24.
chromatography (HPLC) has proven a
milestone in the drug discovery and allowed As quoted earlier in this review, Gel
faster separations of fragile biological permeation/Molecular exclusion
macromolecules. Liquid chromatography chromatography can be effectively applied to
LC/MS is more suitable for biomedical biological samples of proteins, fatty acids
applications than GC/MS because almost all where the differing decisive factor is the
biomolecules are heat sensitive. Furthermore, molecular mass of the components of the
a combination of various mass spectrometers mixture to be analyzed. Gel permeation
has been used even for proteins directly. chromatography with differential
Improving the sensitivity of nuclear magnetic refractometry25 is used to obtain molecular
resonance spectrometry (NMR) has permitted weight distributions (MWD) of poly-(ε-
a direct connection with LC. Fast LC analysis caprolactams).
using a column switching technique was Supercritical Fluid chromatography has choice
introduced for aromatic amino acid metabolites over LC And GC as quoted above because of
and guanidino compounds22. the much lower mobile phase viscosity, higher
After the lead compounds are selected, the diffusitivity and lower column pressure drop,
next steps involve pharmacological, metabolic the packed column supercritical fluid
and pharmacokinetic studies for lead chromatography(pSFC) has made pSFC-
26
optimization. For these studies high sensitivity MS , a very powerful tool for high-throughput,
and selectivity is required. HPLC coupled with qualitative, and quantitative analyses in drug
tandem mass spectrometry i.e. HPLC-MS/MS. discovery. The SFC has wide range of
As well LC coupled with nuclear magnetic applicability to rapid method development,
resonance methods LC-NMR, LC coupled with structure characterization and achiral/chiral
Infrared methods LC-IR methods has proved purification. PrepSFC has been used to purify
its application in the drug discovery. fatty acid esters, synthesis intermediates,
Novel development in this field has been the steroids, most importantly, chiral compounds.
evolution of ultra performance liquid The technique has become more attractive
chromatography (UPLC) which enables use of because it offers high speed, better efficiency,
short columns to be used (5 cm or less) and unique selectivity and it has aqueous-free
rapid analyses (e.g., 5 min or even less than 1 purification capabilities.
min). The subsequent development is then Once the lead has optimized for it therapeutic
UPLC-MS/MS, UPLC-DAD, UPLC-NMR which potential then the analytical methods are
has made DMPK (1) analysis possible in developed which will be utilized during
hardly any time, which has fasten the lead manufacturing, of drug or dosage form. The
optimization step and trimmed down the time methods are validated and approved for using
286
IJRPC 2013, 3(2) Manisha Chavan et al. ISSN: 22312781
in the production department. These methods purity, strength, presence of any degradation
are identification tests, impurity testing, assay, products. Chromatographic techniques (HPLC,
stability, the dosage form content uniformity, HPTLC) have played a crucial role in stability
dissolution, etc. As per requirement and studies for evaluation of the decomposition of
specificity of the test component, the the drug, presence of possible degradation
chromatographic techniques are opted and products, strength of active drug.
implemented to accomplish one of the step of The objective of the cleaning validation32 is to
drug discovery. verify the effectiveness of the cleaning
Assessment of identify of the active ingredient procedure for removal of product residues,
in the test sample or drug formulation is degradation products, preservatives,
utmost important. It can be affected using LC- excipients, and/or cleaning agents as well as
PDA or LC-MS 27. It is mandatory to the control of potential microbial contaminants.
characterize the impurity profile to establish In addition one need to ensure there is no risk
the therapeutic safety of the drug candidate in associated with cross-contamination33of active
pharmaceutical research. Many of the ingredients. The analytical method involved in
governing regulations like ICH, USFDA has here should be sensitive, specific, fast and
emphasized on identification of impurities in accurate to establish the assurance that the
Active Pharmaceutical ingredients. It will no be equipments used in manufacturing are free of
exaggerate if one says that impurity profiling is the above unwanted impurity, presence of
impossible without chromatographic methods. which may alter the safety and efficacy of the
Chromatographic methods along with drug product. HPLC, UPLC techniques have
spectroscopic detection technique in established their role in pharmaceutical
identification of the impurities has brought cleaning validation.
milestone in the drug discovery and IPQC testing are integral part during
development of pharmaceutical industry. manufacturing process, which give assurance
Various hyphenated techniques LC-MS LC- that any process in manufacturing is running
NMR, LC-NMR-MS, GC-MS, and LC-MS/MS28 as per the laid standards and will produce the
are conducted for these purpose depending products with predetermined specifications.
upon the chemical and physical status of the HPLC, GC, UPLC studies are commonly
sample. Obviously assay, content uniformity utilized to check drug release, dissolution
and dissolution testing are important from the testing, content uniformity etc.
standpoint of consumers’ safety and Identification of leachable is utmost important
therapeutic effect of dosage form. One has to in pharmaceutical manufacturing.
follow the pharmacopoeial norms for the Chromatographic techniques have justified its
methods to be used. IP, BP, USP and many role in detection of leachable.
more pharmacopoeias has described the
chromatographic methods and conditions CONCLUSION
while performing the tests. In the drug discovery and development
The stability testing 29, 30 is conducted to process the chromatography has proven a
provide evidence on how the quality of a drug crucial role. It may be concluded that drug
substance or drug product varies with time discovery phenomenon is incomplete with out
under the influence of a variety of temperature, chromatographic techniques. Depending on
humidity, and light, and to establish a re-test the nature of analyte if proper
period for the drug substance or a shelf life for chromatographic method is supported with
the drug product and recommended storage suitable detection technique, the analysis is no
conditions. The stability program31 also longer a challenge. Appliance of selective and
includes the study of product-related factors specific chromatographic technique in the
that influence its quality, for example, various steps of the drug discovery has
interaction of API with excipients, container declined the time and cost of drug research
closure systems and packaging materials. from discovery to manufacturing stage.
After conducting these studies, the drug
product or formulation is tested for its quality,
287
IJRPC 2013, 3(2) Manisha Chavan et al. ISSN: 22312781
REFERENCES
1. Shulamit Levin, High Performance 11. Mahesh Attimarad, KK Mueen Ahmed,
Liquid Chromatography (HPLC) in the Bandar E Aldhubaib, Sree Harsha,
pharmaceutical analysis, High-performance thin layer
Medtechnica, Feb 2010. chromatography: A powerful analytical
2. Robert L. Grob Ph, Eugene F. Barry, technique in pharmaceutical drug
Modern Practice of Gas discovery, Pharmaceutical Methods, ,
Chromatography, Fourth Edition, John an addendum to Journal of Young
Wiley & Sons, IncJuly 2004, 605-641. Pharmacist, Year : 2011, Volume :
3. Chromatography: James M. 2 ,Issue : 2,Page : 71-75
Miller.Concepts and Contrasts, 2nd 12. A B Roge, S N Firke, R M Dhane, V J
edition, John Wiley & Sons, Inc, 2005, Gunjkar, S M Vadvalkar, Novel
37-44 Achievement of HPLC: UPLC,
4. J Cazes, R.P.W. Scott, International Journal of PharmTech
Chromatography Theory, New York Research, Vol.3, No.3, , July-Sept
Dekker, 2002 John Wiley & Sons, 2011,pp1423-1429
2005, 520. 13. UPLC: A Permanent Technique in
5. THE ROYAL SOCIETY OF Pharmaceuticla Analysis, Ashok
CHEMISTRY, Modern Chemical Kumar, Gautam Saini, Anroop Nair
techniques, Unilever 5. and Rishabh Sharma, Acta Poloniae
Chromatography, 116-159 Pharmaceutica ñ Drug Research,
6. Corrado Sarzanini, Recent 2012,Vol. 69 No. 3 pp. 371-380,
developments in ion chromatography, 14. Michael E. Swartz UPLC : An
Elsevier Journal of Chromatography Introduction and Review, Journal of
A, 956 (2002) 3–13 Liquid Chromatography & Related
7. D.A. Skoog, F.J. Holler, S.R. Crouch, Technologiesw, 28:, 2005, 1253–
Instrumental Analysis, Cengage 1263.
Learning, 2007.836, 858, 865, 885, 15. Michael E. SwartzUltra Performance
893, 981-921, 923-925, 927. Liquid Chromatography, (UPLC): An
8. Analytical Chiral Separation Methods, Introduction, Sepration Science
(IUPAC Recommendations 1997) Refined, May, 2005, 9-14.
Pure &App/. Chem., Vol. 69, No. 7, 16. Shulamit Levin, High Performance
pp. 1997. Liquid Chromatography (HPLC) in the
9. MM. Srivastava , An Overview of pharmaceutical analysis,
HPTLC: A Modern Analytical Medtechnica, Feb 2010
Technique with Excellent Potential for 17. Hage DS.,Affinity chromatography: a
Automation, Optimization, review of clinical applications. Cliical
Hyphenation, and Multidimensional Chemistry, 1999 May;45(5):593-615.
Applications, High-performance thin- 18. http://www.alzforum.org/drg/tut/tutorial
layer chromatography (HPTLC) 2011, .asp
pp 3-24 19. Sudberg S, Sudberg EM, Terrazas J,
10. 2 Kaul N, Dhaneshwar SR, Agrawal H, Sudberg S, Patel K, Pineda J, Fine B,
Kakad A, Patil B, Application of HPLC Fingerprint analysis and the
and HPTLC for the simultaneous application of HPTLC to the
determination of tizanidine and determination of identity and quality of
rofecoxib in pharmaceutical dosage botanicals, from an industry
form, Journal of Pharmaceutical and perspective, Journal of AOAC
biomedical analysis, 2005 Feb International, 2010 Sep-
7;37(1):27-38. Oct;93(5):1367-75.
288
IJRPC 2013, 3(2) Manisha Chavan et al. ISSN: 22312781
20. Alexander Hillisch, Rolf Hilgenfeld, 30. Kim Huynh-Ba, Handbook of Stability
Modern Methods of Drug Discovery, Testing in Pharmaceutical
Springers, 2003, 98. Development, Springer Science &
21. Gerald Gu¨ bitz, and Martin G. Business Media, 2009, 1.
Schmid, Chiral Separation by 31. World Health Organization, Annex 2,
Chromatographic and Stability testing of active
Electromigration Techniques. A pharmaceutical ingredients and
Review : Biopharmaceutics and drug finished pharmaceutical products
Disposition, (2001), 22: 291–336. WHO Technical Report Series, No.
22. Hanai T. Chromatography and 953, 2009, 88.
computational chemical analysis for 32. Q7A Good Manufacturing Practice
drug discovery, Current Medicinal Guidance for Active Pharmaceutical
Chemistry, 2005;12 (5):501-25. Ingredients, Cleaning Validation ,
23. Mensch J, Noppe M, Adriaensen J, August 2001, ICH, 34.
Melis A, Mackie C, Augustijns P, 33. GUIDE-0028, Cleaning Validation
Brewster ME Novel generic Guidelines, Drugs and health
UPLC/MS/MS method for high products, Health Canada.
throughput analysis applied to
permeability assessment in early Drug
Discovery, Journal of Chromatography
B – Analytical technologies in the
biomedical and Life Sciences, 2007
Mar 1;847(2):182-7. Epub 2006 Nov
13.
24. Bonnerjera, J., Oh, S., Hoare, M.,
Dunhill, P., The right step at the right
time. Bio/Technology, 4, 954-958
(1986),
25. Elena Mateos1, Vicente L. Cebolla1,
Luis Membrado1, Elena Piera, and
Miguel A. Caballero, Journal of
Chromatogr Science (2007) 45 (8):
524-530.
26. Yining Zhao, Pat Sandra, Gregory
Woo, Samuel Thomas, Kyung Gahm
and David SeminPacked-Column
Supercritical Fluid Chromatography–
Mass Spectrometry for Drug
Discovery Applications
Pharmaceutical Discovery,
November/December, 2004, 1-8.
27. Gilliard J.A, Ritter, C., Use of
simulated liquid chromatography--
diode array detection data for the
definition of a guide curve in peak
purity assessment by spectral
comparison, Journal of
Chromatography A, Volume 786,
issue 1 (October 24, 1997), p. 1-11.
28. Kavita Pilaniya, Harish K.
Chandrawanshi, Urmila Pilaniya,
Pooja Manchandani, Pratishtha Jain,
and Nitin Singh Recent trends in the
impurity profile of pharmaceuticals, J
Adv Pharm Technol Res. 2010 Jul-
Sep; 1(3): 302–310.
29. Stability Testing of new Drug
Substances and Products, ICH Topic
Q 1 A (R2),(CPMP/ICH/2736/99),
August 2003, 4.
289